🇺🇸 FDA
Pipeline program

Capecitabine(Aibin)

capecitabine-oxaliplatin

Phase 3 small_molecule active

Quick answer

Capecitabine(Aibin) for Stage III Esophageal Squamous Cell Carcinoma is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Stage III Esophageal Squamous Cell Carcinoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials